Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial
Discussion
This is the first randomised clinical trial assessing dipeptidyl peptidase-4 inhibition therapy in psoriasis. We hypothesise that sitagliptin therapy in combination with NB-UVB improves psoriasis severity compared to NB-UVB monotherapy.
Trial registration
ClinicalTrials.gov Identifier NCT02347501 (Date of registration: 27 January 2015).
Source: Trials - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Genetics | Heart | Hormones | Insulin | Januvia | Marketing | Obesity | Psoriasis | Research | Skin | Skin Biopsy | Study